AbstractSeveral articles have appeared over the last years devoted to mental side effects during zonisamide (ZNS) treatment. In this study, we were particularly interested in psychotic episodes. Seventy-four epileptic patients with a history of ZNS treatment were surveyed retrospectively over the period spanning 1 March 1984 to 30 June 1994. They were divided into two groups according to the presence or absence of psychotic episodes during ZNS treatment. We analysed various factors pertaining to psychotic episodes during ZNS treatment. Of the 74 patients 14 had psychotic episodes. We found that the incidence of psychotic episodes during ZNS treatment was several times higher than the previously reported prevalence of epileptic psychosis, an...
Psychiatric adverse effect associated with anti-seizure drugs has been well-recognized in human medi...
Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placeb...
Background: Sibutramine is a weight loss agent recently withdrawn from the European market due to ca...
AbstractSeveral articles have appeared over the last years devoted to mental side effects during zon...
AbstractWe treated 27 children with idiopathic epilepsy with zonisamide monotherapy over a period of...
Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of ...
AbstractZonisamide safety was evaluated based on a postmarketing surveillance study of patients trea...
AbstractThis study examined the efficacy and safety of zonisamide as monotherapy in pediatric patien...
Thesis (M.Med)-University of Natal, 1993.Neuroleptic drugs are essential in the treatment of schizop...
Several lines of scientific evidence showed that topiramate may induce psychotic symptoms when used ...
Background: Zolpidem is a non-benzodiazepine medication which selectively affects GABA A receptors a...
Background and Purpose: Zonisamide (ZNS) is a useful antiepileptic drug with a broad therapeutic spe...
AIM: Hypnagogic and hypnopompic hallucinations are characteristic symptoms of narcolepsy, as are exc...
Objective: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS...
Previous studies have shown, although not consistently, that first generation antipsychotics (FGA) a...
Psychiatric adverse effect associated with anti-seizure drugs has been well-recognized in human medi...
Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placeb...
Background: Sibutramine is a weight loss agent recently withdrawn from the European market due to ca...
AbstractSeveral articles have appeared over the last years devoted to mental side effects during zon...
AbstractWe treated 27 children with idiopathic epilepsy with zonisamide monotherapy over a period of...
Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of ...
AbstractZonisamide safety was evaluated based on a postmarketing surveillance study of patients trea...
AbstractThis study examined the efficacy and safety of zonisamide as monotherapy in pediatric patien...
Thesis (M.Med)-University of Natal, 1993.Neuroleptic drugs are essential in the treatment of schizop...
Several lines of scientific evidence showed that topiramate may induce psychotic symptoms when used ...
Background: Zolpidem is a non-benzodiazepine medication which selectively affects GABA A receptors a...
Background and Purpose: Zonisamide (ZNS) is a useful antiepileptic drug with a broad therapeutic spe...
AIM: Hypnagogic and hypnopompic hallucinations are characteristic symptoms of narcolepsy, as are exc...
Objective: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS...
Previous studies have shown, although not consistently, that first generation antipsychotics (FGA) a...
Psychiatric adverse effect associated with anti-seizure drugs has been well-recognized in human medi...
Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placeb...
Background: Sibutramine is a weight loss agent recently withdrawn from the European market due to ca...